市場調査レポート

商品コード

1707977

フィルフィニッシュ製造市場規模、シェア、成長分析、製品タイプ別、医薬品タイプ別、エンドユーザー別、地域別 - 産業予測 2025～2032年

Fill Finish Manufacturing Market Size, Share, and Growth Analysis, By Product Type (Consumables, Equipment), By Drug Type (Biologics, Small Molecules), By End-user, By Region - Industry Forecast 2025-2032

出版日: 2025年04月08日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 775,496円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 907,184円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,038,872円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.32円

全表示
概要
目次

概要

サンプル依頼リストに入れる

フィルフィニッシュ製造市場規模は2023年に167億米ドルと評価され、2024年の182億7,000万米ドルから2032年には374億9,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは9.4％で成長する見通しです。

2023年10月現在、COVID-19との世界の闘いは、ワクチン開発とドラッグデリバリーシステムを中心に、製薬・バイオテクノロジー分野を活気づけています。155を超える化合物と約115のワクチン候補が研究開発中であり、業界は顕著な成長を遂げる態勢にあります。ヒドロキシクロロキンのような確立された治療に対する需要の急増は、効果的なCOVID-19管理ソリューションに対する緊急の必要性を強調し、特に供給不足に直面している富裕層市場において、メーカーに有利な機会を生み出しています。現在、最終製品製造の先端技術が消費者ニーズの高まりに対応し、バイオ医薬品の成長を後押ししています。さらに、非経口投与用のプレフィルドシリンジの人気が高まっていることから、市場力学が強化され、今後数年間で業界の堅調な軌道が強化されると予測されます。

市場概要
消耗品
- プレフィルドシリンジ
- バイアル
- ガラスバイアル
- プラスチックバイアル
- カートリッジ
- アンプル
- ストッパーとシール
- バイアルストッパー
- アルミ圧着キャップ
- プランジャー
- ニードル
装置
- 充填機
- クロージング/シーリングマシン
- 検査機
- 凍結乾燥装置
- ラベリングマシン
- キャッピングマシン
- 統合システム

フィルフィニッシュ製造市場規模：医薬品タイプ別& CAGR（2025-2032）

市場概要
生物学的製剤
- モノクローナル抗体
- ワクチン
- 細胞・遺伝子治療
- 組み換えタンパク質
小分子
ワクチン
その他の注射剤

フィルフィニッシュ製造市場規模：エンドユーザー別& CAGR（2025-2032）

市場概要
製薬会社
バイオ医薬品企業
契約製造組織（CMO）

フィルフィニッシュ製造市場規模：地域別& CAGR（2025-2032）

北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2024年）
主な市場企業が採用した戦略
最近の市場動向
企業の市場シェア分析（2024年）
主要企業の企業プロファイル
- 企業の詳細
- 製品ポートフォリオ分析
- 企業のセグメント別シェア分析
- 収益の前年比比較（2022-2024年）

主要企業プロファイル

Thermo Fisher Scientific Inc.（USA）
Cytiva（USA）
Fujifilm Holdings Corporation（Japan）
OPTIMA Packaging Group GmbH（Germany）
Curia Global, Inc.（USA）
Baxter International Inc.（USA）
Becton, Dickinson and Company（USA）
Aenova Group（Germany）
SGD Pharma（France）
Groninger & Co. GmbH（Germany）
West Pharmaceutical Services, Inc.（USA）
Stevanato Group（Italy）
Syntegon Technology GmbH（Germany）
Robert Bosch GmbH（Germany）
Gerresheimer AG（Germany）
Schott AG（Germany）
IMA Group（Italy）
AptarGroup, Inc.（USA）
Nipro Corporation（Japan）
Vetter Pharma-Fertigung GmbH & Co. KG（Germany）

結論と提言

Product Code: SQMIG35H2229

Fill Finish Manufacturing Market size was valued at USD 16.7 billion in 2023 and is poised to grow from USD 18.27 billion in 2024 to USD 37.49 billion by 2032, growing at a CAGR of 9.4% during the forecast period (2025-2032).

As of October 2023, the global fight against COVID-19 continues to energize the pharmaceutical and biotechnology sectors, particularly in vaccine development and drug delivery systems. With over 155 drug compounds and approximately 115 vaccine candidates in research and development, the industry is poised for notable growth. A surge in demand for established treatments like hydroxychloroquine underscores the urgent need for effective COVID-19 management solutions, creating lucrative opportunities for manufacturers, especially in affluent markets facing supply shortages. Advanced technologies in fall-finish manufacturing now respond to escalating consumer needs, propelling biopharmaceutical growth. Additionally, the rising popularity of prefilled syringes for parenteral dosing is predicted to enhance market dynamics, reinforcing the industry's robust trajectory in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Fill Finish Manufacturing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Fill Finish Manufacturing Market Segments Analysis

Global Fill Finish Manufacturing Market is segmented by Product Type, Drug Type, End-user and region. Based on Product Type, the market is segmented into Consumables and Equipment. Based on Drug Type, the market is segmented into Biologics, Small Molecules, Vaccines and Other Injectables. Based on End-user, the market is segmented into Pharmaceutical Companies, Biopharmaceutical Companies and Contract Manufacturing Organizations (CMOs). Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Fill Finish Manufacturing Market

The Fill Finish Manufacturing market is primarily driven by the increasing demand for biologics, including vaccines, monoclonal antibodies, and gene therapies. As the complexity of these biologics rises, ensuring their sterility throughout the filling and packaging processes becomes essential, leading to higher operational costs. Consequently, facilities are investing in advanced fill-finish technologies to meet the growing need for safe and efficient production of these critical drugs. This investment is vital for maintaining the integrity of biologics while satisfying market demand, ultimately propelling the growth of the Fill Finish Manufacturing sector.

Restraints in the Fill Finish Manufacturing Market

The global fill finish manufacturing sector is facing a significant challenge due to a shortage of skilled professionals who are proficient in operating advanced manufacturing technologies and software. This lack of expertise hampers the effective adoption of automation and other technological innovations, particularly in regions where the pharmaceutical industry is still emerging. As a result, the growth and modernization of the fill finish manufacturing market are hindered, limiting its potential to improve efficiency and productivity. Addressing this skills gap is crucial to unlock the full benefits of technological advancements in the industry and facilitate its development.

Market Trends of the Fill Finish Manufacturing Market

The fill-finish manufacturing market is currently experiencing a significant surge driven by the rising demand for biologics and biosimilars. As pharmaceutical companies strive to deliver innovative therapies, there is a notable shift towards enhancing production capabilities. This trend is prompting manufacturers to invest in advanced technologies and streamlined processes aimed at improving production efficiency, ensuring product quality, and adhering to stringent regulatory standards associated with these complex biologics. Additionally, the proliferation of personalized medicine is further propelling the need for specialized fill-finish services, thus transforming the competitive landscape and driving growth within the industry by facilitating faster and more reliable product delivery to meet market demands.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Studies
Regulatory Landscape
Raw Material Analysis

Global Fill Finish Manufacturing Market Size by Product Type & CAGR (2025-2032)

Market Overview
Consumables
- Prefilled syringes
- Vials
- Glass Vials
- Plastic Vials
- Cartridges
- Ampoules
- Stoppers & Seals
- Vial Stoppers
- Aluminum Crimp Caps
- Plungers
- Needles
Equipment
- Filling Machines
- Closing/Sealing Machines
- Inspection Machines
- Lyophilizers
- Labeling Machines
- Capping Machines
- Integrated Systems

Global Fill Finish Manufacturing Market Size by Drug Type & CAGR (2025-2032)

Market Overview
Biologics
- Monoclonal Antibodies
- Vaccines
- Cell & Gene Therapies
- Recombinant Proteins
Small Molecules
Vaccines
Other Injectables

Global Fill Finish Manufacturing Market Size by End-user & CAGR (2025-2032)

Market Overview
Pharmaceutical Companies
Biopharmaceutical Companies
Contract Manufacturing Organizations (CMOs)

Global Fill Finish Manufacturing Market Size & CAGR (2025-2032)

North America (Product Type, Drug Type, End-user)
- US
- Canada
Europe (Product Type, Drug Type, End-user)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product Type, Drug Type, End-user)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product Type, Drug Type, End-user)
- Brazil
- Rest of Latin America
Middle East & Africa (Product Type, Drug Type, End-user)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Thermo Fisher Scientific Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cytiva (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fujifilm Holdings Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OPTIMA Packaging Group GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Curia Global, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Baxter International Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aenova Group (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SGD Pharma (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Groninger & Co. GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
West Pharmaceutical Services, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stevanato Group (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Syntegon Technology GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Robert Bosch GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Gerresheimer AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Schott AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IMA Group (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AptarGroup, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nipro Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vetter Pharma-Fertigung GmbH & Co. KG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments